Receive 30% off all Monoclonal IHC antibodies with code "MONO-IHC-30"! Offer valid for US customers and available internationally through distributors.

phospho-PRKCA(S657/Y658) Polyclonal Antibody

Applications

  • WB

Reactivity

  • Human
Overview
Catalog # bs-70613r
Product Name phospho-PRKCA(S657/Y658) Polyclonal Antibody
Applications WB
Specificity This antibody detects an 82kDa* protein corresponding to the molecular mass of phosphorylated PKC_ on SDS-PAGE immunoblots of neonatal rat brain lysate. Similar results were observed in human SKN-SH, endothelial, and HeLa cells, as well as rabbit spleen fibroblasts and rat pituitary cells.
Reactivity Human
Specifications
Conjugation Unconjugated
Host Rabbit
Source Phospho-PKC_ (Ser-657/Tyr-658) synthetic peptide corresponds to amino acid residues around serine 657 and tyrosine 658 of human PKC_.
Modification Site S657/Y658
Clonality Polyclonal
Clone # #REF!
Isotype IgG
Purification Antigen Affinity purification
Storage Buffer PBS + 1 mg/ml BSA, 0.05% NaN3 and 50% glycerol
Storage Condition Storage at -20C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20C.
Target
Swiss Prot P17252
Synonyms PKCalpha, PKCbeta, PKCgamma
Background The Protein Kinase C (PKC) family of homologous serine/threonine protein kinases is involved in a number of processes such as growth, differentiation, and cytokine secretion. At least eleven isozymes have been described. PKC consists of a single polypeptide chain containing four conserved regions (C) and five variable regions (V). The N-terminal half interacts with PKC activators Ca2+, phospholipid, diacylglycerol, or phorbol ester, while the C-terminal half contains the catalytic domain. The conventional PKC subfamily (_, _1, _II, and _) is regulated by both Ca2+ and diacylglycerol. The PKC pathway represents a major signal transduction system that is activated following ligand-stimulation of transmembrane receptors by hormones, neurotransmitters and growth factors. The phosphorylation of multiple sites in conventional PKCs regulates their activity. In mast cells, FceRI stimulation leads to phosphorylation of tyrosine 658 and 662 of PKC_ and PKC_I respectively. This phosphorylation requires autophosphorylation of serine 657 and 661 in these respective kinases.
Application Dilution
WB 1:500-2000